Literature DB >> 16520553

Phospholipase D is activated and phosphorylated by casein kinase-II in human U87 astroglioma cells.

Bong-Hyun Ahn1, Gyesik Min, Yoe-Sik Bae, Young-Seuk Bae, Do Sik Min.   

Abstract

Elevated expression of protein casein kinase II (CKII) stimulated basal phospholipase D (PLD) activity as well as PMA-induced PLD activation in human U87 astroglioma cells. Moreover, CKII-selective inhibitor, emodin and apigenin suppressed PMA-induced PLD activation in a dose-dependent manner as well as basal PLD activity, suggesting the involvement of CKII in the activation of both PLD1 and PLD2. CKII was associated with PLD1 and PLD2 in co-transfection experiments. Furthermore, CKII induced serine/threonine phosphorylation of PLD2 in vivo, and the multiple regions of PLD2 were phosphorylated by CKII in vitro kinase assay using glutathione S-transferase-PLD2 fusion protein fragments. Elevated expression of CKII or PLD increased cell proliferation but pretreatment of cells with 1-butanol suppressed CKII-induced cell proliferation. These results suggest that CKII is involved in proliferation of U87 cells at least in part, through stimulation of PLD activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520553     DOI: 10.1038/emm.2006.7

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  12 in total

1.  Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.

Authors:  Yugang Liu; Jian Zheng; Yan Zhang; Zhaotao Wang; Yang Yang; Miaochun Bai; Yiwu Dai
Journal:  Neurochem Res       Date:  2016-07-09       Impact factor: 3.996

2.  IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3).

Authors:  Karen M Henkels; Kathleen Frondorf; M Elba Gonzalez-Mejia; Andrea L Doseff; Julian Gomez-Cambronero
Journal:  FEBS Lett       Date:  2010-11-21       Impact factor: 4.124

3.  Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion.

Authors:  Qing Ye; Samuel Kantonen; Julian Gomez-Cambronero
Journal:  J Mol Biol       Date:  2012-12-10       Impact factor: 5.469

Review 4.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

5.  Depletion of mitochondrial DNA up-regulates the expression of MDR1 gene via an increase in mRNA stability.

Authors:  Wan Lee; Hyo Im Choi; Mi Jin Kim; Seung Yoon Park
Journal:  Exp Mol Med       Date:  2008-02-29       Impact factor: 8.718

6.  Cellular and subcellular localization of endogenous phospholipase D6 in seminiferous tubules of mouse testes.

Authors:  Mun-Yong Lee; Do Sik Min; Tae-Ryong Riew; Soojin Kim; Xuyan Jin; Hong Lim Kim; Won Chan Hwang; Minju Kang; Eun Sun Yang
Journal:  Cell Tissue Res       Date:  2021-03-30       Impact factor: 5.249

7.  Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.

Authors:  Amanda R Noble; Norman J Maitland; Daniel M Berney; Martin G Rumsby
Journal:  Br J Cancer       Date:  2017-11-14       Impact factor: 7.640

8.  PLD1 overexpression promotes invasion and migration and function as a risk factor for Chinese glioma patients.

Authors:  Wenjun Tang; Richu Liang; Yonghong Duan; Qiaoling Shi; Xiaofei Liu; Yongshi Liao
Journal:  Oncotarget       Date:  2017-07-05

Review 9.  Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review.

Authors:  Shailaja Mahajan-Thakur; Sandra Bien-Möller; Sascha Marx; Henry Schroeder; Bernhard H Rauch
Journal:  Int J Mol Sci       Date:  2017-11-17       Impact factor: 5.923

Review 10.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.